These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15333082)

  • 1. Early recurrence of atrial fibrillation: does the shock waveform matter?
    Joglar JA; Page RL
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):898-900. PubMed ID: 15333082
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story.
    Savelieva I; Camm AJ
    Europace; 2011 Feb; 13(2):149-52. PubMed ID: 21252194
    [No Abstract]   [Full Text] [Related]  

  • 3. A shock in time saves ablation?
    Siu CW; Tse HF; Lau CP
    Europace; 2011 Feb; 13(2):155-6. PubMed ID: 21186227
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of rectilinear biphasic waveform energy versus truncated exponential biphasic waveform energy for transthoracic cardioversion of atrial fibrillation.
    Kim ML; Kim SG; Park DS; Gross JN; Ferrick KJ; Palma EC; Fisher JD
    Am J Cardiol; 2004 Dec; 94(11):1438-40. PubMed ID: 15566922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low energy biphasic waveform cardioversion of atrial arrhythmias in pediatric patients and young adults.
    Liberman L; Hordof AJ; Altmann K; Pass RH
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1383-6. PubMed ID: 17201846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrillation testing in patients with atrial fibrillation.
    Lim HS; Lip GY
    Europace; 2009 Aug; 11(8):1108-9. PubMed ID: 19549676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies.
    Rashba EJ; Gold MR; Crawford FA; Leman RB; Peters RW; Shorofsky SR
    Am J Cardiol; 2004 Dec; 94(12):1572-4. PubMed ID: 15589022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. A survey of a Cochrane review].
    Osbak P; Egede R; Jensen GB
    Ugeskr Laeger; 2008 Nov; 170(47):3870-3. PubMed ID: 19014742
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion of atrial fibrillation for maintenance of sinus rhythm: a road to nowhere.
    Wyse DG; Anter E; Callans DJ
    Circulation; 2009 Oct; 120(14):1444-52. PubMed ID: 19805661
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Shelton R
    Eur Heart J; 2004 Dec; 25(23):2174; author reply 2174-5. PubMed ID: 15571844
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapeutic efficiency of complex-ACE inhibitor (perindopril) and traditional antiarrhythmic-treatment for prevention atrial fibrillation paroxysms after successful electric cardio version].
    Abuladze GV; Dzhindzholiia NR; Narsiia EV; Dzhincharadze BZ; Kadzhaia TZ
    Georgian Med News; 2008 Feb; (155):17-9. PubMed ID: 18401049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biphasic shock waveform for cardioversion of atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2005 Jan; 144(1):4-7, 72. PubMed ID: 15719812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction.
    Boriani G; Raviele A; Biffi M; Gasparini G; Martignani C; Valzania C; Diemberger I; Corrado A; Raciti G; Branzi A
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):974-80. PubMed ID: 16174019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fortuitous effect of TASER shock misleading.
    Dawes DM; Ho JD
    Ann Emerg Med; 2009 Feb; 53(2):286-7. PubMed ID: 19167625
    [No Abstract]   [Full Text] [Related]  

  • 19. A placebo-controlled, crossover comparison of oral triazolam prior to sham patient-activated shock delivery during sinus rhythm in a group of patients with recurrent atrial fibrillation.
    Mitchell AR
    J Cardiovasc Electrophysiol; 2006 Sep; 17(9):E1; author reply E2. PubMed ID: 16948731
    [No Abstract]   [Full Text] [Related]  

  • 20. Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion.
    Varounis C; Dagres N; Maounis T; Panagiotakos D; Cokkinos DV
    Europace; 2007 Aug; 9(8):633-7. PubMed ID: 17507365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.